Targeted therapy for gynecologic cancer is an advanced approach to cancer treatment that uses medicines designed to act on specific molecules, proteins, or biological pathways involved in the growth and spread of cancer cells.
Unlike conventional chemotherapy, which generally affects rapidly dividing cells, targeted therapy is designed to act on specific characteristics of cancer cells. It may be considered for selected patients based on the type of cancer, stage, molecular profile, biomarker results, and previous treatments.
Dr. Sarika Gupta, a gynecologic cancer specialist in Delhi, provides personalized evaluation and treatment planning for women with gynecologic cancers.
Targeted therapy works by interfering with specific mechanisms that cancer cells use to grow, survive, or spread. Because these targets can differ between patients and cancer types, targeted therapy is not suitable for everyone.
Before treatment is recommended, doctors may review the patient's pathology, molecular testing, genetic testing, and relevant biomarkers to determine whether a particular targeted medicine may be appropriate.
The goal is to select treatment based on the biological characteristics of the individual cancer.
Targeted medicines may be used in selected cases of several gynecologic cancers.
Some ovarian cancers have specific genetic or molecular characteristics that can help guide treatment decisions.
Depending on the cancer type and biomarker results, certain targeted medicines may be considered as part of treatment for selected patients, either alone or in combination with other cancer therapies.
Endometrial cancer consists of different molecular subtypes. Molecular and pathology testing can provide information about the biological behavior of the tumor.
For selected patients with advanced or recurrent endometrial cancer, biomarker-directed or targeted treatments may be considered as part of the overall treatment plan.
Patients with advanced or recurrent cervical cancer may be considered for systemic therapies based on their disease characteristics and previous treatment.
The appropriate treatment depends on the cancer stage, tumor characteristics, previous therapies, overall health, and relevant biomarkers.
A personalized treatment plan may consider:
This evaluation helps the cancer team determine whether targeted therapy is an appropriate option.
Targeted therapy and chemotherapy work differently.
Chemotherapy generally attacks rapidly dividing cells, whereas targeted therapy is designed to interfere with specific molecular targets involved in cancer growth or survival.
In some situations, targeted therapy may be combined with chemotherapy, immunotherapy, surgery, radiation therapy, or other systemic treatments.
The appropriate combination depends on the individual cancer diagnosis.
Targeted therapy can cause side effects, and these vary depending on the specific medicine used.
Possible side effects may include:
Patients receiving targeted therapy require regular medical monitoring so that treatment response and possible side effects can be assessed.
Targeted therapy is only one component of modern gynecologic oncology. Depending on the patient's diagnosis, treatment may include:
Dr. Sarika Gupta develops treatment plans based on the patient's individual cancer characteristics and clinical needs.
Dr. Sarika Gupta focuses on gynecologic oncology and personalized cancer care, helping women understand their diagnosis and available treatment options.
For patients who may benefit from targeted therapy, treatment decisions can be guided by pathology and appropriate molecular or biomarker testing. This approach helps identify treatments that are relevant to the specific biology of the cancer.
Patients searching for targeted therapy for gynecologic cancer in Delhi, targeted cancer treatment in Paschim Vihar, or a gynecologic oncologist in West Delhi can consult Dr. Sarika Gupta for specialist evaluation and treatment planning.
Patients from Paschim Vihar, Punjabi Bagh, Rajouri Garden, Janakpuri, Pitampura, Rohini, and surrounding areas of West Delhi and North West Delhi can seek consultation.
Targeted therapy is not appropriate for every gynecologic cancer. A detailed evaluation of the cancer type, stage, pathology, and relevant biomarkers is important before considering this treatment.
Consult Dr. Sarika Gupta to understand whether targeted therapy may be an appropriate part of your gynecologic cancer treatment plan in Delhi.
Action Cancer Hospital, Paschim Vihar, New Delhi
+91 98119 13335
Mon - Sat: 9:00 AM - 7:00 PM